Clinical Trial: AVANTI - Avelox® in Acute Exacerbations of chroNic bronchiTIs

Study Status: Completed
Recruit Status: Completed
Study Type: Observational




Official Title: AVANTI - Avelox® in Acute Exacerbations of Chronic Bronchitis

Brief Summary:

The objective of this global non-interventional study is to evaluate the impact of Acute Exacerbation of Chronic Bronchitis(AECB) on the patient and the community as well as the safety and effect of a treatment with Moxifloxacin tablets in daily life clinical practice. This includes data on the course of symptom relief, speed of return to normal daily life activities as well as records on adverse events.

This study will be performed in accordance with international guidelines like EMEA (EMEA, EUDRALEX Volume 9A, Pharmacovigilance for Medicinal Products for Human Use) as well as local laws.